Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Mice with human gene experienced hair loss when treated with DHT.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormones and genes affect hair growth and male baldness.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

New acne treatments show promise as alternatives to traditional therapies.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Antibody treatments show promise for hair loss but need more research.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.